Recombinant multi-species SCGB1D1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCGB1D1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the lipophilin subfamily, part of the uteroglobin superfamily, and is an ortholog of prostatein, the major secretory glycoprotein of the rat ventral prostate gland. This gene product represents one component of a heterodimeric molecule present in human tears whose elution profile is consistent with prostatein, a tetrameric molecule composed of three peptide components in heterodimers. Assuming that human lipophilins are the functional counterparts of prostatein, they may be transcriptionally regulated by steroid hormones, with the ability to bind androgens, other steroids and possibly bind and concentrate estramustine, a chemotherapeutic agent widely used for prostate cancer. Although the gene has been reported to be on chromosome 15, this sequence appears to be from a cluster of genes on chromosome 11 that includes mammaglobin 2. [provided by RefSeq, Jul 2008]
The Alternative Names of target: LIPA,LPHA,LPNA,Lipophilin-A,SCGB1D1,Secretoglobin family 1D member 1

Target products collectionGo to SCGB1D1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1265-Ag-1/ GM-Tg-hg-SE1265-Ag-2 Human SCGB1D1 protein Human
GM-Tg-rg-SE1265-Ag-1/ GM-Tg-rg-SE1265-Ag-2 Rat SCGB1D1 protein Rat
GM-Tg-mg-SE1265-Ag-1/ GM-Tg-mg-SE1265-Ag-2 Mouse SCGB1D1 protein Mouse
GM-Tg-cynog-SE1265-Ag-1/ GM-Tg-cynog-SE1265-Ag-2 Cynomolgus/Rhesus macaque SCGB1D1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1265-Ag-1/ GM-Tg-felg-SE1265-Ag-2 Feline SCGB1D1 protein Feline
GM-Tg-cang-SE1265-Ag-1/ GM-Tg-cang-SE1265-Ag-2 Canine SCGB1D1 protein Canine
GM-Tg-bovg-SE1265-Ag-1/ GM-Tg-bovg-SE1265-Ag-2 Bovine SCGB1D1 protein Bovine
GM-Tg-equg-SE1265-Ag-1/ GM-Tg-equg-SE1265-Ag-2 Equine SCGB1D1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1265-Ag-1/ GM-Tg-hg-SE1265-Ag-2; GM-Tg-rg-SE1265-Ag-1/ GM-Tg-rg-SE1265-Ag-2;
GM-Tg-mg-SE1265-Ag-1/ GM-Tg-mg-SE1265-Ag-2; GM-Tg-cynog-SE1265-Ag-1/ GM-Tg-cynog-SE1265-Ag-2;
GM-Tg-felg-SE1265-Ag-1/ GM-Tg-felg-SE1265-Ag-2; GM-Tg-cang-SE1265-Ag-1/ GM-Tg-cang-SE1265-Ag-2;
GM-Tg-bovg-SE1265-Ag-1/ GM-Tg-bovg-SE1265-Ag-2; GM-Tg-equg-SE1265-Ag-1/ GM-Tg-equg-SE1265-Ag-2
Products Name SCGB1D1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SCGB1D1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SCGB1D1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.